Today on Pharmaceutical Processing
Senator Manchin asks Biden to oust Woodcock over Aduhelm row
The West Virginia Senator Joe Manchin III (D-W. Va) sent a letter to President Joe Biden expressing his dismay regarding the FDA’s approval of Aduhelm (aducanumab), the controversial Alzheimer’s treatment from Biogen (NSDQ:BIIB). The nonprofit watchdog group Public Citizen sent a broadly similar letter to HHS Secretary Xavier Becerra to “express its outrage” over the approval and to demand…
Sepha unveils high performance leak tester for pharma packaging testing
Leak-testing and packaging specialist Sepha (Belfast) is launching a leak tester for container closure integrity testing (CCIT) applications that can detect leaks as small as 1 µm. Known as the Multi-Q HD, the device supports the non-destructive detection of defects in pharmaceutical containers including parenteral packaging formats, which have experienced growth during the pandemic, thanks…
Sponsored Content See More >
Noble expands its services for its clients into Human FactorsHuman Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug…
Regulatory See More >
Senator Manchin asks Biden to oust Woodcock over Aduhelm row
The West Virginia Senator Joe Manchin III (D-W. Va) sent a letter to President Joe Biden expressing his dismay regarding the FDA’s approval of Aduhelm (aducanumab), the controversial Alzheimer’s treatment from Biogen (NSDQ:BIIB). The nonprofit watchdog group Public Citizen sent a broadly similar letter to HHS Secretary Xavier Becerra to “express its outrage” over the approval and to demand…
Facility See More >
Avantor acquires RIM Bio to bolster presence in Asia
The chemicals and materials specialist Avantor (NYSE:AVTR) has acquired RIM Bio, a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical applications. The acquisition gives Avantor its first single-use production facility in Asia and doubles its global single-use cleanroom space. Avantor also has single-use manufacturing facilities in the Americas and Europe. The RIM Bio…
Supply Chain See More >
How silica can support cold chain logistics
In the early days of the pandemic, the subarctic storage requirements for mRNA COVID-19 vaccines sparked renewed interest in the cold chain. One potentially overlooked element of the cold chain is silica, according to the specialty chemicals company Evonik. The company states that its Aerosil fumed silica supports passively cold transport units using cool packs…
Recalls See More >
J&J must reportedly throw out 60M COVID-19 vaccine doses from Emergent plant
Another large amount of doses of Johnson & Johnson’s COVID-19 vaccine produced at an embattled manufacturing plant reportedly have to be thrown out. The New York Times reported that the FDA told J&J that about 60 million doses of the single-dose vaccine produced at Emergent BioSolutions’ Baltimore plant can’t be used because of possible contamination.…
GSK, Pfizer and J&J among the most-fined drug companies, according to study
Nostrum Laboratories recalls Type 2 diabetes drug over contamination problems
Flu vaccination worries rise in South Korea following deaths
